LUNG TIN IP ATTORNEYS
Minimally Invasive Medical Instrument
Publish Time:2019-04-09
Endoscope infection is the most top infection in the cross-infection risks of medical devices. There was an official report from the American institute of health research. From 2000 to 2015, the cases of endoscopic cross-infection disclosed in the US peer-reviewed literature shown that there were 147 people came to cross infection, The main causes of infection include broken endoscope, incomplete manual cleaning and disinfection, and failure of automatic cleaning and disinfection equipmenteach account for about one-third of the total. Each of these causes accounts for a third of the total. 
 
The high-definition endoscope technology based on CCD image sensor technology is monopolized by a few manufacturers for a long time. The rise of CMOS image sensor technology is expected to break the technology monopoly to reduce the production cost of HD endoscope, and promote the expansion of the endoscope market. Through technology introduction and absorption and independent research and development, the gap between the quality of medical endoscope products of domestic enterprises and those of international advanced enterprises is narrowing. At present, China's medical endoscope has got rid of the situation of relying solely on the import, the domestic endoscope has also realized the export, and maintain the high-speed growth momentum. The global endoscope industry has grown rapidly in recent years and is expected to reach $26 billion by 2022, according to EvaluateMedTech.
 
CPLT makes a survey of the technology situation and pattern in the related technology field and masters the current status of the technologies and patents of endoscope products on the market by taking the patented technology as the entry point. CPLT provides a comprehensive understanding of the technology architecture and patent distribution of the endoscope industry. CPLT clarifies the patent landscaping of all competitors in the industry and reveals the potential patent infringement risks in the target marke.